The stock market is down Wednesday, with the Dow Jones Industrial Average down 0.04%, the Nasdaq down 0.04% and the S&P 500 down 0.14%. Today's winners are a clinical trial management firm that is going private and a semiconductor company reporting better-than-expected earnings. Today's losers are a biosciences firm that is offering more equity to the public and an auto parts supplier that reported earnings that missed Wall St.'s view.
These are Wednesday's market winners and losers.
Shares of BioClinica Inc. (NASDAQ: BIOC) are up 19.37% to $7.21 on trading volume of 5 million shares. JLL Partners Inc., a private equity firm, will buy the company for $7.25 a share, or about $123 million. Before Wednesday, the 52-week high was $6.59.
Shares of Freescale Semiconductor Ltd. (NYSE: FSL) are up 16.55% to $14.44 on trading volume of 2.9 million shares. Although the company lost $0.15 a share in the fourth quarter, it was better than the $0.18 a share Wall St. analysts polled by Reuters expected. The 52-week high is $17.84.
Shares of Ventrus Biosciences Inc. (NASDAQ: VTUS) are down 20.12% to $2.62 on trading volume of 1.3 million shares. The company has priced 5.8 million shares of common stock at $2.50. The 52-week low is $1.99.
Shares of Meritor Inc. (NYSE: MTOR) are down 14.77% to $4.56 on trading volume of 2.7 million shares. The auto parts supplier announced a first-quarter loss of $0.22 a share, far worse than the $0.04 a share Wall St. analysts expected. The 52-week low is $3.83.
Follow Samuel on Twitter: SWeigley
Filed under: 24/7 Wall St. Wire Tagged: BIOC, featured, FSL, MTOR, VTUS